Asthma drug can block SARS-CoV-2 protein: IISc researchers - BSI bureau

The US FDA drug montelukast has been around for more than 20 years

According to a new study by researchers at the Indian Institute of Science (IISc) in Bengaluru, a drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus… [+997 chars]

full article...